Investors interested in Finance stocks should always be looking to find the best-performing companies in the group. CME Group (CME) is a stock that can certainly grab the attention of many investors, ...

In recent trading, shares of CME Group Inc (Symbol: CME) have crossed above the average analyst 12-month target price of $270.39, changing hands for $272.36/share. When a stock reaches the target ...

CME Group CME has been analyzed by 17 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table provides a quick overview of their ...

XRP experiences a 3.32% price drop as CME launches XRP futures on Monday. Explore the factors influencing XRP's current ...

CME Group thrives on market volatility ... in trading during a prolonged period of inactivity. All in all, the outlook for the coming quarters seems favorable. There is enough uncertainty ...

What Happened: After conducting a thorough analysis, Carey sold 3,000 shares of CME Group. This information was disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission on Monday.

Below is a look at the 8-14 day outlook. Sign up below for a FREE trial of our daily fundamental and technical commentary! Futures trading involves substantial risk of loss and may not be suitable ...

CME Group traded as high as $271.22 and last traded at $270.10, with a volume of 1462780 shares. The stock had previously closed at $262.54. Several other equities research analysts have also ...

CME Group (NASDAQ:CME) stock slipped 1.4% in Wednesday ... Q1 adjusted EPS of $2.80, just missing the average analyst estimate of $2.81, increased from $2.52 in Q4 2024 and $2.50 in last year's ...

are pivotal factors anticipated to impact CME Group’s revenue and earnings positively. Analysts expect revenue to grow annually over the next three years, although slightly slower than the ...

CHICAGO - CME Group Inc. (NASDAQ ... InvestingPro subscribers can access detailed analysis and 8 additional key insights about CME's performance and outlook in the comprehensive Pro Research ...